Start Date
September 30, 2023
Primary Completion Date
December 18, 2023
Study Completion Date
December 18, 2023
Idylla EGFR_IUO/3.20 Mutation Test
Clinical Performance Study Protocol for Idylla EGFR\_IUO/3.20 Mutation Test The EGFR\_IUO/3.20 is automated on the Idylla™ Platform, which executes the entire process from sample to result including sample liquefaction, cell lysis, real-time PCR amplification/detection, and data analysis and reporting.
Lead Sponsor
Collaborators (1)
AstraZeneca
INDUSTRY
Biocartis NV
INDUSTRY